Podcasts by The Drug Discovery World Podcast

The potential of metabolomics&COVID-19 Vaccine Development from 2021-02-23T12:00

Today's episode is titled The potential of metabolomics & COVID-19 Vaccine DevelopmentListen

The power of precision and the potential of human tissue chips from 2021-02-09T12:00

Today's episode is titled: The power of precision and the potential of human tissue chips, and covers 2 ar...

Therapeutic Antibodies - New tools to enhance the antibody drug pipeline from 2021-01-31T22:10:42.023393

Therapeutic antibodies are the fastest growing class of drugs, with continuous increases in the number of innovator and biosimilar drugs in development. We discuss the rise of therapeutic antibodi...

The Importance Of Heterocyclic Compounds In Anti-Cancer Drug Design from 2021-01-31T22:10:42.023393

Heterocycles are key structural components of many of the anti-cancer drugs available on the market. In this episode, we look at some of the most important heterocyclic compounds currently implicat...

Immuno-Oncology's Biomarker Dilemma - How To Add Value In An Uncertain Development Landscape from 2021-01-31T22:10:42.023393

Given their ability to promote long-term survival in a percentage of cancer patients, PD-1/PD-L1 checkpoint inhibitors have fast become foundational cancer therapies. But knowing which patients may...

Drug Discovery In The Age Of Big Data – The Impact Of RNAi & CRISPR/Cas9 Technologies from 2021-01-31T22:10:42.023393

This episode discusses how RNA interference and CRISPR/Cas9 technologies are helping to build better mouse models and push drug discovery into a new era. For more information on Drug Discovery Wor...

Phenotypic Screening - Advancing The Science From Discovery To Regulatory Science from 2021-01-31T22:10:42.023393

Phenotypic screening is transforming drug discovery as advances are made in development of human-based physiologically-relevant in vitro systems. Integration of phenotypic drug discovery approache...

The Business Side of Drug Discovery from 2021-01-26T12:00

Today's episode on the topic of The Business Side of Drug Discovery, covers 3 articl...

Innovation and Opportunity in Drug Discovery from 2021-01-12T12:00

Today's episode on the topic of Innovation and Opportunity in Drug Discovery, covers 3 articles taken from the most recent Fall issue of DDW. 

Listen

2030 Life Sciences and Health in the Digital Age (Part 2) from 2020-12-22T12:00

The Pistoia Alliance has developed a research paper which sets out to consider what the life science, biopharma R&D and healthcare ecosystem might look like in 20...

2030 Life Sciences and Health in the Digital Age (Part 1) from 2020-12-08T12:00

This article is the first in a two-part series based on The Pistoia Alliance report. Written in retrospect from the world as it is in 2030, it looks at how health...

Evolution of User Experience for life sciences from 2020-11-24T12:00

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that ce...

Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic from 2020-11-10T12:00

Non-alcoholic fatty liver disease (NAFLD) has quietly become one of the most common causes of chronic liver disease in the modern world. If this prevalence is all...

Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency from 2020-10-27T12:00

This article will describe, with examples, how understanding the likely mechanisms of false positives in advance of screening informs the design of the hit triage, thus increasing the likelihood...

The COVID-19 Race: how mouse models will help researchers cross the finish line from 2020-10-13T12:00

The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe.

Amid the worldwide health emergency create...

Cryo-EM accelerates drug discovery by delivering previously intractable structural insights from 2020-09-22T12:00

Cryo-electron microscopy (cryo-EM), a powerful biophysical technique that can analyse molecular assemblies, is changing the paradigm in structure-based drug design.

As targets become more...

The Reality of Virtual Pharmaceutical Companies from 2020-09-08T12:00

In this episode, we discuss the oxymoronic proposition of a Virtual Pharmaceutical Company (VPC) and the typical adopted business model, as well as provide examples of such companies currently t...

Race To COVID-19 Cure - The Core Model for solving the pandemic crisis (Part 2) from 2020-08-25T12:00

Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronav...

Race To COVID-19 Cure - The Core Model for solving the pandemic crisis (Part 1) from 2020-08-11T12:00

Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronav...

Creating Vaccines, drop by drop from 2020-07-28T12:00

The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new.

Microfluidics technolog...

The COVID-19 antiviral race: we're all in this together from 2020-07-14T12:00

In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of t...

Using Live-Cell Imaging Systems to Transform Perspectives in Drug Discovery from 2020-06-23T12:00

Live-cell imaging has transformed the study of cell behaviour and function. The technique allows researchers to monitor internal cell structures, interactions and processes in real-time, and ove...

Fail Early, Fail Fast - A phenotypic rescue approach from 2020-06-09T12:00

New disease targets frequently emerge in literature, but the thorough target validation required to consider these targets for a drug discovery programme is often lacking.

In pharmacologi...

Unlocking Clinical Trial Data to Uncover New Therapeutic Opportunities from 2020-05-26T12:00

This article discusses opportunities, challenges and best practices in leveraging infrastructure excellence and AI to unlock the value of early or inconclusive clinical trial data. The goal... d...

From human genome to global genome - why precision medicine must address genetic diversity from 2020-05-12T12:00

The publication of the first human genome sequence more than 15 years ago marked the start of a new era in medicine. In the years since then, researchers have greatly expanded knowledge of gene-...

Optimising Phenotypic Screening - Single-cell analysis versus 3D multicell analysis from 2020-04-28T12:00

In light of the high failure rate of compounds when they are subjected to clinical testing, we are seeing a renaissance in phenotypic screening in drug discovery. However, most phenotypic screen...

How Artificial Intelligence is Transforming Drug Design from 2020-04-14T12:00

AI could create a streamlined, automated approach to drug discovery, trawling vast datasets to identify targets, find candidate molecules and predict synthesis routes. Getting there will require...

Safety First - Automating cell line development from 2020-03-31T12:00

Developing and maintaining cell cultures in a stable and sterile environment is of paramount importance to protect samples and increase overall success of drug discovery pipelines. Cell lines ar...

Application of bioinformatics in support of precision medicine from 2020-03-17T12:00

Bioinformatics has played a major role in gene sequencing diagnostics and has been an essential tool to investigate the genetic causes of disease. With the support of new technologies and tools,...

3D Organoid Cell Culture - Optimising disease models for research and drug discovery from 2020-03-03T12:00

In this episode, we examine the use of 3D organoid cell culture systems as applied to cancer research and the development of novel anti-oncologic drugs. Collectively, this transition from 3D sph...

Bitten by the Bug - A flurry of investments fuel microbiome drug discovery from 2020-02-18T12:00

It has become quite evident that the microbiome has the potential to impact drug discovery in vital ways. In addition to impacting study reproducibility and variability, the microbiome may influ...

From Genotype to Phenotype: Leveraging functional genomics in oncology from 2020-02-04T12:00

Drug discovery is increasingly informed by genomics, which can significantly boost the chances of a novel therapy successfully navigating the lengthy journey from bench to bedside. But despite t...

Flow Cytometry - The advanced systems overcoming drug discovery pain points from 2020-01-21T12:00

Flow cytometry is an invaluable technique for the characterisation of highly heterogeneous cell populations.

Thanks to improvements in throughput, automation and multichannel detection ca...

Cell Therapy - Falling short of its potential? from 2020-01-07T12:00

Despite major investment in the field, few cell therapies have gained regulatory approval with limited commercial success.

The success of therapeutic products is defined by three factors:...

Fostering Multidisciplinary Collaboration in Drug Discovery from 2019-12-10T12:00

Drug discovery teams combine specialists with in-depth knowledge from a variety of scientific disciplines. Such diversity in thought worlds poses a challenging exercise in cross-disciplinary col...

Automated Cell-based Assays: Novel tools overcome the barriers to drug discovery success from 2019-11-26T12:00

In this episode, we look at how commercial products and services are facilitating the automation of cell-based assays to advance drug discovery and accelerate the delivery of new medicines to pa...

Immunotherapy - Knocking Out Cancer With a One-Two Punch from 2019-11-12T12:00

New immunotherapies that integrate innate and adaptive immune responses may increase efficacy against many cancers, and have the potential to expand the range of tumours and patients that can be...

Automating Automation - How close are we to Artificial Intelligence impact? from 2019-10-29T12:00

In terms of consistency, repeatability, known errors and sheer volume, there exists perhaps no better collection of data for computer learning than that emerging from automated processes.

Integrated Platform Drug Discovery and Development Companies - Part 3: Comparative analysis from 2019-10-15T12:00

Recently there have been attempts by small-to-medium sized pharmaceutical companies to create in-house, integrated platform-DDD (PD3) capabilities. This strategy does not come without risks, but...

Integrated Platform Drug Discovery and Development Companies - Part 2 from 2019-10-08T12:00

Recently there has been some attempt to amalgamate platform technologies within start-up and earlystage drug discovery and development companies to increase drug candidate pipeline numbers. This...

Integrated Platform Drug Discovery and Development Companies - Part 1 from 2019-10-01T12:00

Technology was lauded as the saviour of the drug discovery and development process during the late 1990s. A myriad of independent companies developed and offered ‘innovative’ tools, technologies...

Increasing Drug Discovery Success With 3D Cell Culture Systems from 2019-09-24T12:00

Drug candidates often fail in the clinic for two reasons: they lack efficacy or possess an adverse toxicity profile. These failures can come at a high cost, especially when drug candidates have ...

Mining Plant Genomes - A modern approach to herbal healing from 2019-09-10T12:00

Plants are stationary soldiers. Rooted to one spot, they are not able to chase nutrients or flee from herbivores and pathogens. So in addition to the basic metabolites they synthesise for their ...

Advanced Automated Liquid Handling Systems – How they are Reshaping Drug Discovery from 2019-08-27T12:00

Once the domain of high-throughput screening (HTS) applications, automated liquid handling systems are now used ubiquitously in drug discovery and have been fundamental in increasing throughput,...

Systems Pharmacology - When multi-targeting is advantageous (Part 2 of 2) from 2019-08-13T12:05

The safety and efficacy of therapeutic drugs still requires improvement. However, the advent of both systems biology and precision medicine has stimulated a rethink on the process of therapeutic...

Systems Pharmacology - When multi-targeting is advantageous (Part 1 of 2) from 2019-08-13T12:00

The safety and efficacy of therapeutic drugs still requires improvement. However, the advent of both systems biology and precision medicine has stimulated a rethink on the process of therapeutic...

How Mergers and Acquisitions Will Drive Oncology Research in 2019 from 2019-07-30T12:00

2019 got off to a fast start for oncology drug discovery, with numerous mergers, acquisitions and collaborations announced in quick succession.

These ventures provide a window into key tr...

Beyond SEND: Leveraging non-clinical data to drive translational research forward from 2019-07-16T12:00

This article will discuss some of the potential use cases that Standard for Exchange of Nonclinical Data (SEND), datasets can support. Both to advance translational research across multiple rese...

The Evolution of Transdermal Drug Delivery and Treating Migraine from 2019-07-02T12:00

Transdermal Drug Delivery (TDD) is a promising method for drug application that has major advantages over some of the most common routes of drug administration.

In most cases, oral drug d...

Good Laboratory Practice - To GLP or not to GLP? from 2019-06-18T12:00

Good Laboratory Practice (GLP), are federal regulations that require implementation of a robust quality management system to ensure the validity, integrity and reliability of non-clinical safety...

3D Cell Culture - Engineering Composable, Disease-Tunable 3D Human Microtissues for Drug Discovery from 2019-06-04T12:00

Recent technological and scientific developments now make it possible to build human in vitro 3D tissue models and even connected 3D tissue/organ models recapitulating human biology and pathophy...

The Growth of Organoids in Cancer Drug Discovery from 2019-05-21T12:00

Will the automated expansion of organoids help improve the productivity of cancer drug discovery?

Increasingly, complex cell-based assays and tissues are routinely used as part of cancer ...

R&D at Astrazeneca - Improving Drug Development Productivity With Better Predictivity from 2019-05-07T12:00

Changing demands in global healthcare over the past 15 years have led to greater complexity and spiralling costs in drug development. The average price tag of taking a new drug from discovery to...

Current Trends in RNA-based Therapeutic Development from 2019-04-23T12:00

Cellular RNAs play crucial roles during disease progression and represent a diverse and largely untapped class of biomolecules that can be exploited for drug development.

RNA species incl...

Genetically-Engineered Models: The Value of Precious GEMs from 2019-04-09T12:00

Genetically-engineered animal models (GEMs) are critical tools for drug discovery and development, but intellectual property (IP) concerns can complicate access.

As pharma and biotech inc...

Analytical Biophysical Tools To Accelerate Discovery of Therapeutic Antibodies from 2019-04-02T12:00

The innate ability of antibodies to bind their targets with high affinity and exquisite specificity is leveraged in the discovery of therapeutic antibodies to treat a broad range of diseases inc...

Therapeutics Discovery at MD Anderson Cancer Center from 2019-03-26T12:00

The mission at The University of Texas MD Anderson Cancer is to eradicate cancer, which remains a major cause of mortality worldwide. It is the second leading cause of death in the United States...

Induced Pluripotent Stem Cells (iPSCs) – Unlocking their full potential for Drug Discovery from 2019-03-19T12:00

Human stem cells were once viewed primarily as regenerative materials for tissue repair through cell therapies. However, advances in technologies and protocols mean that induced pluripotent stem...

Cell Therapy&Gene Therapy - The emerging fourth pillar of healthcare systems from 2019-03-12T12:00

The latest data from the Association for Regenerative Medicine (ARM) showed that there are more than 704 regenerative medicine companies worldwide, including cell therapy and gene therapy, and 7...

How Phenotypic CRISPR Screening is Revolutionising Drug Discovery from 2019-03-05T12:00

Research in drug discovery and biotechnology increasingly exploits gene editing at industrial scale in order to identify and validate new biological targets for precision medicines.

The d...

Cell Therapy - Preserving Cell Integrity and Viability to Drive Discovery from 2019-02-26T12:00

Cell therapy is poised to play a pivotal role in the development of precision and personalised medicines that will transform healthcare for millions of patients worldwide.

Involving the d...

The Future of Drug Discovery - Cutting-edge technologies meet traditional paradigms in assay development from 2019-02-19T12:00

With more than 1,500 drugs approved by the Food and Drug Administration (FDA) on the market, the easiest disease targets are already covered.

Today’s scientists are challenged to find new...

Data Driven Transformation In Drug Discovery from 2019-02-12T12:00

This episode presents a review of the current approaches to data management and application within the drug development and research setting, highlighting major critical challenges and emerging ...

Ion Channels - Increasingly Enticing Targets For Drug Discovery from 2019-02-05T12:00

Drug discovery focused on ion-channel proteins began generating great value for pharmaceutical R&D programmes more than 30 years ago, giving rise to medicines still important in the pharmacopeia...

Bringing Immuno-Oncology Together: How An Immunologist&Oncologist Collaborate from 2019-01-29T12:00

For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) have demonstrated what can be achieved when the t...

A Marriage of Technologies for Immuno-Oncology In Vivo Studies from 2019-01-22T12:00

Discovering and validating novel therapeutic targets to add to the immuno-oncology arsenal will require refined preclinical models that meet the needs for suitability, scalability and clinical r...

3D cellular Imaging - Advances and Considerations for High-Content Screening from 2019-01-15T12:00

Commercially available high-content imaging (HCI) systems, introduced in the 1990s, have provided the scientific community with a platform that offers a unique set of tools ideal for advancing h...

Antibiotics&Antimicrobial Resistance (AMR) - A Global Perspective from 2019-01-08T12:00

Antibiotic resistance is at a crossroad. In the world today, deaths in low income countries from Antimicrobial Resistance (AMR) are predicted to rise dramatically by 2050. We know how to stop th...

The Mass Spectrometry Innovations Simplifying Drug Discovery Workflows from 2018-12-18T15:54:23

Mass spectrometry (MS) has long been a valuable tool for drug discovery, and steady advances in its capabilities and performance have generated powerful insights for the pharmaceutical industry....

Magnetic Resonance Imaging (MRI) In Drug Development from 2018-12-11T14:00

Magnetic Resonance Imaging (MRI) can be used to provide quantitative measurements in the form of imaging biomarkers. These measurements have a number of attractive characteristics: They are non-...

Metabolomics - A Playbook for Functional Genomics from 2018-12-04T16:21:30

If we have learned anything from scientific research in the last 20 years, it is that finding cures to complex diseases is difficult. Despite the promise of the genomic revolution, disease progr...

Treating Cancer - How Natural Killer Cell Therapy Will Transform Immunotherapy from 2018-11-27T15:12:07

Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours – a major shift in oncology treatment.

Yet even ...

Disruptive Approaches To Accelerate Drug Discovery and Development (Part 3) – Emergent Intelligence from 2018-11-20T16:31:37

The staggering clinical trial failure rate of experimental drugs indicates that despite huge investments in novel technologies over the years, productivity gains in the pharmaceutical industry r...

Disruptive Approaches To Accelerate Drug Discovery and Development (Part 2) – The Core Model from 2018-11-16T15:19:09

The staggering failure rate of experimental drugs in clinical trials indicates that despite huge investments in novel technologies, productivity gains in the pharmaceutical industry remain elusi...

Disruptive Approaches To Accelerate Drug Discovery and Development (Part 1) – Tools&Technologies from 2018-11-13T16:42:44

The staggering failure rate of experimental drugs in clinical trials indicates that despite huge investments in novel technologies, productivity gains in the pharmaceutical industry remain elusi...

The Human Microbiome - A New Frontier in Drug Discovery from 2018-11-06T15:16:42

There is a new phenomenon sweeping the globe (or at least sweeping the imagination of people around the globe). It is the human gut microbiome and the role it may play in the future of human hea...

Microfluidics - Driving Innovation and Streamlining Single Cell Analysis from 2018-10-30T15:17:29

Microfluidic platforms that harness picodroplet technology (picolitre volume aqueous droplets in stabilised oil emulsions) are unlocking the potential of single cell analysis to enable exciting ...

Unleashing High-Throughput Reaction Screening the Unchained Way (Bonus White Paper Episode) from 2018-10-26T09:35:07

A successful high-throughput approach to reaction screening requires rational and systematic exploration of a broad set of variables to achieve optimization expeditiously.

There are many ...

Precision Medicine Drugs - Pleonasm or Reality? from 2018-10-23T13:53:41

The Drug Discovery and Development (DDD) process continues to slowly evolve to address the perpetual problem of the complexity and uniqueness of human metabolism and physiology.

More rece...

Linked Data & Semantic Technologies in Healthcare & Life Sciences (Bonus Webinar Episode) from 2018-10-19T15:30:21

Semantic technologies - based on advanced statistics, data mining, machine learning and knowledge management - have existed for years, but are gaining much more momentum dealing with the growing ne...

Biologics Drug Discovery - Driving Strategic Improvements With Scientific Informatics from 2018-10-16T14:54:34

Adoption of a scientific informatics system is essential to the success of every drug discovery organisation. This episode discusses how we can drive strategic improvements in biologics drug discov...

Full Length Isoform Sequencing (Iso-Seq) Yields a More Comprehensive View of Gene Activity from 2018-10-09T10:00:38

RNA-seq has revolutionised how scientists can interrogate gene expression. But after years of performing RNA-seq studies with short-read sequencers, many have realised that there is more to be disc...

Robotics Within and Beyond The Lab from 2018-10-02T14:34:08

Recent interest in areas such as the Internet of Things, smart glasses and machine learning have all led to initial exploration through webinars and conference panels, but none seem to have generat...

Oral Peptide Therapeutics - A Holy Grail or Quixotic Quest? from 2018-09-25T14:43:06

Technologies have been honed to overcome many of the challenges of administering peptide therapeutics orally, but obstacles remain before drug developers can fully realise the vast potential.
<...

How High-Throughput CRISPR is set to Deliver Knockout Performance in Drug Discovery from 2018-09-18T10:32:18

CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential in the field of gene therapy, advances in its high...

Breaking Down Silos In Drug Development - Why Interdisciplinary Integration Is Fundamental For Pharma's Future from 2018-09-11T14:32:06

In this episode, we consider the symptoms and consequences of a silo culture in drug development, and look at how interdisciplinary integration should be at the heart of every pharma business model...

Practicalities Of Conducting Replication Studies In Preclinical Cancer Biology from 2018-09-04T13:36:43

The first results for the Reproducibility Project: Cancer Biology offer insights into the time and cost of conducting replication studies in preclinical cancer biology.

With this first est...

The Kinetics of Drug Receptor Binding (Bonus Webinar Episode) from 2018-08-31T12:00

Optimizing the receptor binding kinetics of new drugs can have significant benefits, ranging from improved duration of action to enhanced efficacy through the insurmountable antagonism of dynamic p...

Kinases - Application of New Assay Technologies to Shed Light on Kinase Drug Discovery from 2018-08-28T14:27:21

The human kinome comprises 518 known protein kinases and more than 20 lipid kinases. Nearly all aspects of control within a cell are modulated by reversible phosphorylation of proteins, mediated by...

SMAC Mimetics: A New Class of Cancer Therapeutics from 2018-08-21T15:21:42

Smac mimetics are a new class of targeted drugs being developed for the treatment of solid tumours and hematologic cancers. Smac mimetics specifically induce apoptotic cancer cell death and block p...

Next-Generation Sequencing in Drug Development from 2018-08-14T14:41:32

This episode summarises some of the technical and regulatory challenges posed by next-generation sequencing technologies and the efforts being made to address them.

Next-Generation Sequenc...

Artificial Intelligence (AI) & Biopharma R&D IT from 2018-08-07T14:44:34

This episode discusses issues around artificial intelligence & Biopharma R&D IT, and outlines how AI can be a potentially transformative technology for the biopharmaceutical and healthcare industri...

Automating Flow Cytometry for Cell-Based Screening in Drug Discovery from 2018-07-31T15:33:55

Flow cytometry is a powerful tool for cell quantitation and analysis across a wide range of clinical and research applications. Most commonly used in the fields of immunology and haematology, recen...

The Cancer Conundrum - Increasing Clinical Success With Early Phase Drug Discovery from 2018-07-24T11:18:52

This episode focuses on increasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enhance cancer drug discovery....

Targeting Kinases for Drug Discovery (Bonus Webinar Episode) from 2018-07-19T12:35:53

Kinases are one of the most widely-studied drug target classes, with over 20 years in the spotlight for drug discovery research. Selecting optimized assays for screening, hit validation, selectivit...

Emerging Drug Discovery Alliance Models from 2018-07-17T14:21:14

The current environment for early-stage drug discovery and development is fluid and the probability of success continues to be challenging.

Advancing an idea from an academic or basic rese...

Novel Drug Targets From Phenotypic Screening from 2018-07-10T15:28:37

Identifying functional molecules with the potential to be developed into new therapeutics is often the sole aim of phenotypic drug discovery. However, the approach also provides valuable opportunit...

Discovery & Development of Inhaled Biopharmaceuticals from 2018-07-03T15:18:40

With the rapid generation of biological screening data and the potential for innovative selection of compounds for screening, the importance of multivendor collaborations together with improvements...

An Update On Hepatitis B (HBV) Therapies from 2018-06-26T16:10:13

The hepatitis B crisis is a worldwide unmet medical need. Hepatitis B (HBV) is the cause of a silent epidemic that has resulted in a worldwide healthcare crisis. Despite the significant burden it p...

Is The Cloud Enabling Bioinformatics To Become The Biology Solutions Domain? from 2018-06-19T14:08:09

In this episode we look at the history and the challenges that exist in the biology field and examine how the cloud, ‘appification’, SaaS, micro services, web tools and other new IT architectures a...

How The B6 Mouse Strain Is Revolutionising Drug Discovery from 2018-06-12T14:37:52

Inbred mice are critical tools in biomedical research and one particular strain, known as C57BL/6 (Black 6 or B6, for short), is rapidly becoming the standard model for many applications and revolu...

Technology Innovation Will Help Prepare Drug Discovery For The Smart Screening Era from 2018-06-05T17:53:17

Drug discovery is undergoing a transformation powered by advances that magnitude more molecules and enable smarter selection of compounds. We are on the cusp of having previously unimaginable amoun...

Raising The Bar On The Biologics Potential from 2018-05-29T14:00

There is continued pressure to fill the drug pipeline and, at the same time, globalisation of personalised medicines is complex, expensive and requires a significant time commitment.

Risk,...

Collaborative Robots Are Redefining Lab Automation from 2018-05-22T14:00

Recent advances in robot technology are going to change the breadth of applications suitable for robots and alter how we think about robotic integration.

For researchers in the drug discov...